A new investigational cancer vaccine developed by Merck & Co. and Moderna is customized based on the genome of each patient's ...
A WuXi AppTec director examines strategies for improving oral PROTAC exposure, from food-effect studies and linker design to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results